EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis

Min Wei, Amirabas Bostani, Nadi Jamalsi, Hasan Baqin, Peng Wen

Archives of Microbiology · 2025

DOI: 10.1007/s00203-025-04422-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, 2025. Verfasst von Min Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shandong Public Health Clinical Center, Shandong University, Shandong, 250013, China. Hauptthemen laut MEDLINE: Gallic Acid, Mycobacterium tuberculosis, Antitubercular Agents, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Development Plan of Medicine and Health Science and Technology of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The persistent rise of multidrug-resistant (MDR) bacteria represents a significant public health challenge, necessitating the exploration of alternative therapeutic options. The slow pace of approval for new anti-tuberculosis (TB) medications underscores the urgent need to identify potential alternative agents. Gallic acid (GA) possesses numerous biological properties, including antibacterial and antiseptic effects. In this study, both standard and MDR strains of M. tuberculosis were utilized to assess the antibacterial efficacy of GA and related mechanisms. GA achieved minimum inhibitory and minimum bactericidal concentrations comparable to those of the examined antibiotics with significantly lower cytotoxicity in the THLE-3 cell line (p-value < 0.05). Furthermore, GA displayed bactericidal properties, enhanced the effectiveness of moxifloxacin and levofloxacin against MDR M. tuberculosis, and modulated the expression of efflux pump genes, specifically Rv1410c and Rv1258c (p-value < 0.001). These results contribute to a deeper understanding of GA's antibacterial potential and suggest a novel alternative approach for managing MDR bacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallic AcidMycobacterium tuberculosisAntitubercular AgentsTuberculosis, Multidrug-ResistantMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialHumansCell LineLevofloxacinMoxifloxacinBacterial Proteins

Stichwörter der Autor:innen

AntibioticDrug-resistantEffluxFlavonoidGallic acidMycobacteriaTuberculosis

Substanzen

Gallic AcidAntitubercular AgentsLevofloxacinMoxifloxacinBacterial Proteins

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Shandong Public Health Clinical Center, Shandong University, Shandong, 250013, China.
  • Medical Laboratory Department, Amir A'lam Hospital, Tehran, Iran.
  • Department of Respiratory and Critical Care Medicine, Shandong Public Health Clinical Center, Shandong University, Shandong, 250013, China. wp1980jn@sina.com.

Förderung

  • Development Plan of Medicine and Health Science and Technology of Shandong Province

Zitieren

APA

Wei, M., Bostani, A., Jamalsi, N., Baqin, H., & Wen, P. (2025). Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis. Archives of Microbiology. https://doi.org/10.1007/s00203-025-04422-z

Vancouver

Wei M, Bostani A, Jamalsi N, Baqin H, Wen P. Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis. Archives of Microbiology. 2025. doi:10.1007/s00203-025-04422-z

BibTeX
@article{Wei2025,
  author = {Wei, Min and Bostani, Amirabas and Jamalsi, Nadi and Baqin, Hasan and Wen, Peng},
  title = {Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis},
  journal = {Archives of Microbiology},
  year = {2025},
  doi = {10.1007/s00203-025-04422-z}
}
Kostenlos starten →